Halotest

Halotest (halotestin, fluoxymesterone) increases strength and endurance. In fact, Halotest is the number one choice for heavy lifters looking to increase their strength. In pre-competition training, this drug can also be very useful for relief and fat burning. It is one of the strongest anabolic androgenic steroids and is derived from methyltestosterone with a modified structure in the chemical formula. Halotest has the highest anabolic and androgenic rating of 1900/850.

Despite the fact that it has such high anabolic properties, its anabolic properties are considered to be almost zero! It acts more like an androgenic agent.

Fluoxymesterone is close in structure to methyltestosterone. It was developed by modifying testosterone in three positions: The 17-alpha-methyl group, the 11-beta-hydroxy group, and the 9-fluoro group.

The first chemical modification allows prolonging the half-life of the drug when taken orally and leveling the damaging effect of the first passage through the liver, while maintaining the maximum concentration of the active substance in the blood.

The second modification is aimed at preventing the enzymatic conversion of the molecule by attaching aromatic rings to it, in other words, the drug is not converted to estrogens. It is supposed to block estrogen and prolactin receptors, which eliminates the risk of gynecomastia, edema, and fat deposition in the female type.
It has also been noted that the drug improves the aerobic performance of athletes in athletics. This is associated with the ability to stimulate erythropoiesis, the synthesis of hemoglobin. At the same time, more red blood cells are able to transport oxygen to the cells more efficiently.

Halotest can be used for fat burning because the drug has been shown to enhance fatty acid oxidation in fast muscle fibers. Although there are also safer and more effective anabolic agents for this purpose, particularly winstrol, testosterone, and oxandrolone.

Associated with an increased rate of dihydrotestosterone formation from testosterone are hypertrophy and hyperplasia of the prostate, the development of prostatic adenoma, and possibly an increased likelihood of developing cancer. The drug’s relatively easy ability to convert to dihydrotestosterone may have further adverse health effects with long-term use.

Halotest is estimated to have 19 times the anabolic ability of testosterone and 8.5 times the androgenic ability of testosterone. Information about the activity of the drug has been obtained experimentally.
Halotestin is toxic to the liver. Athletes who have used the drug often report an enlargement and soreness of the organ. Studies show that the drug certainly leads to increased levels of liver enzymes, indicating a steady process of increased degradation of liver cells under the influence of Halotest.